Up a level |
Colomer-Carbonell, Ariadna, Sanabria-Mazo, Juan P., Hernández-Negrín, Halbert, Borràs, Xavier, Suso-Ribera, Carlos, Garciá-Palacios, Azucena, Muchart, Jordi, Munuera, Josep, D'Amico, Francesco, Maes, Michael, Younger, Jarred W., Feliu-Soler, Albert, Rozadilla-Sacanell, Antoni and Luciano, Juan V. (2022) Study protocol for a randomised, double-blinded, placebo-controlled phase III trial examining the add-on efficacy, cost-utility and neurobiological effects of low-dose naltrexone (LDN) in patients with fibromyalgia (INNOVA study). BMJ Open, 12 (1). ISSN 2044-6055